Corning CapEx decreased by 23.1% to $332.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 59.6%, from $208.00M to $332.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -5.9% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $324.00M | $401.00M | $623.00M | $383.00M | $353.00M | $465.00M | $403.00M | $382.00M | $388.00M | $341.00M | $279.00M | $252.00M | $242.00M | $217.00M | $254.00M | $208.00M | $308.00M | $334.00M | $432.00M | $332.00M |
| QoQ Change | — | +23.8% | +55.4% | -38.5% | -7.8% | +31.7% | -13.3% | -5.2% | +1.6% | -12.1% | -18.2% | -9.7% | -4.0% | -10.3% | +17.1% | -18.1% | +48.1% | +8.4% | +29.3% | -23.1% |
| YoY Change | — | — | — | — | +9.0% | +16.0% | -35.3% | -0.3% | +9.9% | -26.7% | -30.8% | -34.0% | -37.6% | -36.4% | -9.0% | -17.5% | +27.3% | +53.9% | +70.1% | +59.6% |